Engage A-T
Research type
Research Study
Full title
Widening Engagement and Participation in Cancer Screening Research in Ataxia Telangiectasia.
IRAS ID
346015
Contact name
Rupinder Bajwa
Contact email
Sponsor organisation
University of Nottingham
Duration of Study in the UK
1 years, 3 months, 30 days
Research summary
A-T is a complex genetic disease that affects movement, breathing, and significantly increases cancer risk. Although there is currently no cancer screening programme for people with A-T, trials are being developed. In the UK, people affected by A-T come from a wide range of ethnic and cultural backgrounds, with over a third from non-white groups and many speaking languages other than English. These factors may make it harder for some to engage with research or healthcare services.
This study aims to understand the social, cultural, and language barriers that may prevent people with ataxia telangiectasia (A-T), a rare inherited condition, from taking part in cancer screening research and accessing related services. We want to find ways to support people from diverse backgrounds with A-T to participate in future screening trials and programmes.
We will interview 40 people (20 with A-T and 20 caregivers) from under-represented ethnic, cultural, and language groups. These interviews will explore their views and experiences around cancer screening. We will analyse the responses to identify common barriers to participation and access.
A patient and public involvement (PPI) collaborator helped shape this study and is part of the research team. A focus group of stakeholders will guide our recruitment approached to ensure they are inclusive and effective.
We will share our findings and guidance widely with researchers and healthcare providers to help improve inclusion in cancer screening for people with A-T. Results will also be published in medical journals to inform global research efforts.
REC name
West Midlands - Edgbaston Research Ethics Committee
REC reference
25/WM/0213
Date of REC Opinion
18 Nov 2025
REC opinion
Further Information Favourable Opinion